XML 47 R36.htm IDEA: XBRL DOCUMENT v3.20.2
EMPLOYEE STOCK COMPENSATION (Tables)
 9 Months Ended
Sep. 30, 2020
Share-based Payment Arrangement [Abstract]  
Summary of Share-Based Compensation Expense
The following table presents stock-based compensation expense and the related tax benefits for the periods indicated:
Three Months Ended
September 30, 		Nine Months Ended
September 30,
($ in thousands)2020201920202019
Stock options$— $3 $4 $(13)
Restricted stock awards and units1,346 1,491 4,388 3,857 
Total share-based compensation expense$1,346 $1,494 $4,392 $3,844 
Related tax benefits$396 $439 $1,293 $1,130 
Unrecognized Share-Based Compensation Expense
The following table presents unrecognized stock-based compensation expense as of September 30, 2020:
($ in thousands)Unrecognized ExpenseWeighted-Average Remaining Expected Recognition Period
Restricted stock awards and restricted stock units$8,189 2.1 years
Total$8,189 2.1 years
Option Activity
The following table represents stock option activity for the three months ended September 30, 2020:
Three Months Ended September 30, 2020
($ in thousands except per share data)Number of SharesWeighted-Average Exercise Price Per ShareWeighted-Average Remaining Contract TermAggregated Intrinsic Value
Outstanding at beginning of period55,069 $13.96 3.7 years
Outstanding at end of period55,069 $13.96 3.5 years$(210)
Exercisable at end of period55,069 $13.96 3.5 years$(210)

The following table represents stock option activity for the nine months ended September 30, 2020:
Nine Months Ended September 30, 2020
($ in thousands except per share data)Number of SharesWeighted-Average Exercise Price Per ShareWeighted-Average Remaining Contract TermAggregated Intrinsic Value
Outstanding at beginning of period62,521 $13.85 4.3 years
Exercised(7,452)$13.05 5.2 years
Outstanding at end of period55,069 $13.96 3.5 years$(210)
Exercisable at end of period55,069 $13.96 3.5 years$(210)
Nonvested Share Activity
The following table sets forth information regarding unvested stock options for the three and nine months ended September 30, 2020:
Three Months Ended
September 30, 2020		Nine Months Ended
September 30, 2020
Number of SharesWeighted-Average Exercise Price Per ShareNumber of SharesWeighted-Average
Exercise Price
Per Share
Outstanding at beginning of period2,248 $13.75 2,248 $13.75 
Vested(2,248)$13.75 (2,248)$13.75 
Forfeited— $— — $— 
Outstanding at end of period— $— — $— 
Restricted Stock and Restricted Stock Units Activity The following table presents unvested restricted stock awards and restricted stock units activity for the three and nine months ended September 30, 2020:
Three Months Ended
September 30, 2020		Nine Months Ended
September 30, 2020
Number of SharesWeighted Average Grant Date Fair Value Per ShareNumber of SharesWeighted
Average Grant
Date Fair Value
Per Share
Outstanding at beginning of period912,670 $14.91 923,482 $15.74 
Granted (1)
4,457 $11.22 358,593 $13.76 
Vested (2)
(15,881)$15.42 (309,576)$15.92 
Forfeited (3)
(18,005)$16.09 (89,258)$16.69 
Outstanding at end of period883,241 $14.86 883,241 $14.86 
(1)There were zero and 78,771 performance-based shares/units included in shares granted for the three and nine months ended September 30, 2020.
(2)There were zero and 18,473 performance-based shares/units included in vested shares for the three and nine months ended September 30, 2020.
(3)The number of forfeited shares includes aggregate performance-based shares/units of zero and 17,404 for the three and nine months ended September 30, 2020.
Summary of all Outstanding SARs
The following table represents SARs activity and the weighted average exercise price per share as of and for the three months ended September 30, 2020:
Three Months Ended September 30, 2020
($ in thousands except per share data)Number of SharesWeighted-Average Exercise Price Per ShareWeighted-Average Remaining Contract TermAggregated Intrinsic Value
Outstanding at beginning of period1,559,012 $11.60 2.1 years$(1,812)
Outstanding at end of period1,559,012 $11.60 1.9 years$(2,264)
Exercisable at end of period1,559,012 $11.60 1.9 years$(2,264)

The following table represents SARs activity and the weighted average exercise price per share as of and for the nine months ended September 30, 2020:
Nine Months Ended September 30,
($ in thousands except per share data)Number of SharesWeighted-Average Exercise Price Per ShareWeighted-Average Remaining Contract TermAggregated Intrinsic Value
Outstanding at beginning of period1,559,012 $11.60 2.6 years$8,508 
Outstanding at end of period1,559,012 $11.60 1.9 years$(2,264)
Exercisable at end of period1,559,012 $11.60 1.9 years$(2,264)